JG Chemicals announced the sudden and untimely demise of Ashok Bhandari, an Independent Director on its Board, on August 3, 2026. The loss marks the end of a tenure that began on June 30, 2022, during which Bhandari served as a member of several critical governance committees, including the Audit Committee, Nomination and Remuneration Committee, Corporate Social Responsibility Committee, and Risk Management Committee. His passing creates an immediate vacancy in these oversight roles, necessitating a replacement to maintain statutory compliance and board balance.

The company notified the National Stock Exchange of India Ltd (NSE) and the Bombay Stock Exchange (BSE) pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure was made in accordance with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026, dated January 30, 2026. Swati Poddar, Company Secretary and Compliance Officer, signed the intimation, confirming that Bhandari’s membership in all aforementioned committees ceased with effect from August 3, 2026.

Committee Vacancies

Bhandari’s role extended beyond general board oversight; he was integral to the company’s compliance and strategic governance structures. The following table outlines the committees from which he has vacated his seat:

The Board of Directors expressed deep condolences to the bereaved family, citing Bhandari’s valuable guidance and significant role in the company’s strategic growth. As an Independent Director, his presence was crucial for ensuring unbiased oversight of management decisions and protecting shareholder interests.

Regulatory Compliance and Next Steps

The announcement includes Annexure A, detailing the particulars of the change as required under Schedule III of the Listing Regulations. The document confirms the reason for cessation as "Death" and lists the date of cessation as August 3, 2026. No brief profile or relationship disclosures were applicable for this specific filing, as per regulatory norms for such events.

The company must now initiate the process to appoint a new Independent Director to fill the vacancy. This appointment will require approval from the Nomination and Remuneration Committee and subsequent ratification by shareholders at the next general meeting, ensuring continuity in the board’s composition and committee mandates. Until a successor is appointed, the remaining members of the respective committees will continue to function, subject to regulatory requirements regarding quorum and independence ratios.

Jayanti Commercial Private Ltd has disclosed its shareholding in J.G. Chemicals Limited and confirmed that no encumbrances were created on the shares during the financial year ended 31st March, 2026. The declaration was made to the National Stock Exchange of India Ltd and BSE Ltd in compliance with Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This regulation requires promoters to declare annually that they have not created any encumbrances, directly or indirectly, other than those previously disclosed.

Shareholding Details

As on 31st March, 2026, Jayanti Commercial Private Ltd held a total of 31,83,900 shares in J.G. Chemicals Limited. The company stated that neither it nor any persons acting in concert with it made any encumbrance on these shares during the financial year.

Regulatory Compliance

The disclosure was submitted by Shilpa Jhunhunwala, Managing Director of Jayanti Commercial Private Ltd. The filing confirms that the promoter group has adhered to the regulatory requirements regarding the disclosure of shareholding and any potential encumbrances for the specified financial year.